Mainoli, Beatrice http://orcid.org/0000-0002-5295-4346
Duarte, Gonçalo S.
Costa, João
Ferreira, Joaquim
Caldeira, Daniel
Article History
First Online: 11 May 2020
Compliance with ethical standards
:
: This review was an academic project and was not supported by any form of funding.
: Daniel Caldeira has participated in educational meetings and/or attended conferences or symposia (including travel, accommodation and/or hospitality) for Bristol-Myers Squibb, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Merck Serono, Ferrer, Pfizer, Novartis and Roche. Joaquim Ferreira reports grants from GlaxoSmithKline, Grunenthal, Fundação MSD (Portugal), TEVA, MSD, Allergan, Novartis and Medtronic, and also reports consultancy fees from GlaxoSmithKline, Novartis, TEVA, Lundbeck, Solvay, BIAL, Merck-Serono, Merz, Ipsen, Biogen, Acadia, Allergan, Abbvie and Sunovion Pharmaceuticals. In addition, he received personal fees from Faculdade de Medicina de Lisboa and CNS – Campus Neurológico Sénior, personal fees from Advisory Boards from BIAL, and expert testimony from Novartis.